Retrovirus Testing Market: Introduction
· Retrovirus is a type of virus with RNA as its genetic material. It is composed of an enzyme called reverse transcriptase that converts RNA to DNA after infecting a cell. It then integrates its DNA into the host DNA for replication.
· Retroviruses are a group of viruses that belong to the Retroviridae family. Human immunodeficiency virus (HIV) is one of the common retroviruses known to cause diseases in humans. Other forms of retroviruses include human T-cell lymphotropic virus type 1 (HTLV-1), HTLV-2, HIV 1, and HIV 2.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75177
· HTLV-1 is known to cause a type of cancer known as adult T-cell leukemia, and a neurodegenerative condition known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It was the first retrovirus to be discovered, detected, and isolated, followed by the HIV.
· Endogenous retroviruses (ERVs) are persistent features of genomes in various animals. Human ERVs are known to be distributed in the human genome over the course of evolution, making up to 4% of the human DNA.
Key Drivers and Restraints of Global Retrovirus Testing Market
· High prevalence of HIV and increase in awareness about the diagnosis of HIV are driving the global retrovirus testing market. According to UNAIDS, more than 37.9 million people were suffering from HIV at the end of 2018, and over 78% of the population was aware of carrying the infection.
· Retrovirus testing tools act as one of the efficient tools for the identification of the disease. These tolls provide quick results, with significantly high efficacy, thus boosting the retrovirus testing market.
Request COVID Analysis on Retrovirus Testing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75177
· Rise in adoption of in-vitro assays for the diagnosis of retroviruses, owing to the increase in incidence of sexually transmitted diseases, and growth in investments in research and development, are propelling the global retrovirus testing market
· Introduction of technologically advanced and rapid retroviral infection detection technologies, increase in awareness about diagnostic tests, and rise in expenditure on the screening of retroviruses are anticipated to propel the global retrovirus testing market during the forecast period
· Lack of skilled professionals to perform the assays and high cost of retrovirus testing assays and diagnostic kits are projected to hamper the retrovirus testing market during the forecast period
Request Customization on Retrovirus Testing Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75177
North America to Lead Global Retrovirus Testing Market
· In terms of region, the global retrovirus testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
· North America dominated the global retrovirus testing market owing to the increase in awareness about the diagnosis of retrovirus, presence of well-established health care infrastructure, and growth in investments in research and development activities
· Europe followed North America for retrovirus testing in 2018. The region, in turn, was followed by Asia Pacific. The market in Asia Pacific is projected to expand at a rapid pace in the near future. It is likely to be followed by the market in Latin America and Middle East & Africa
Pre Book Retrovirus Testing Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=75177<ype=S
Key Manufacturers Operating in Global Retrovirus Testing Market
Leading players operating in the global retrovirus testing market include:
· Roche Diagnostics Ltd.
· DiaSorin S.p.A.
· Becton, Dickinson and Company
· bioMérieux SA
· Abbott Diagnostics
· Alere Inc.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
